As part of our trust-commitment, we invest in clinical trials to ensure that our devices deliver the safety and efficacy that patients require. Our clinical program is designed to provide data for device approvals, gaining performance outcomes in a variety of clinical scenarios and finding new strategies for improving outcomes.

The PANDA trials evaluate the clinical performance of the BuMA Drug Eluting Stent in a variety of clinical scenarios.

The PIONEER trials evaluate the global clinical performance of the HT Supreme Drug Eluting Stent on a global in a variety of clinical scenarios.